Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 301 | IDYA | IDEAYA BIOSCIENCES INC | Healthcare | 8,014.0 | $267K | 0.07% | +195.0 | +2.5% | $33.32 | -12.1% |
| 302 | NUVL | NUVALENT INC | Healthcare | 2,602.0 | $267K | 0.07% | +64.0 | +2.5% | $102.45 | +4.8% |
| 303 | MGTX | MEIRAGTX HLDGS PLC | Healthcare | 30,570.0 | $265K | 0.07% | +746.0 | +2.5% | $8.66 | +14.2% |
| 304 | ABCL | ABCELLERA BIOLOGICS INC | Healthcare | 75,327.0 | $263K | 0.07% | +2K | +2.5% | $3.49 | +55.9% |
| 305 | NGNE | NEUROGENE INC | Healthcare | 13,033.0 | $263K | 0.07% | +317.0 | +2.5% | $20.16 | +33.3% |
| 306 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 57,895.0 | $261K | 0.07% | +1K | +2.5% | $4.50 | +3.1% |
| 307 | SEPN | SEPTERNA INC | Healthcare | 10,719.0 | $258K | 0.07% | +262.0 | +2.5% | $24.03 | +24.0% |
| 308 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 11,165.0 | $258K | 0.07% | +271.0 | +2.5% | $23.07 | +19.1% |
| 309 | DYN | DYNE THERAPEUTICS INC | Healthcare | 14,150.0 | $257K | 0.07% | +344.0 | +2.5% | $18.13 | +0.2% |
| 310 | IMVT | IMMUNOVANT INC | Healthcare | 10,320.0 | $256K | 0.07% | +251.0 | +2.5% | $24.84 | +34.5% |
| 311 | PRTA | PROTHENA CORP PLC | Healthcare | 26,320.0 | $256K | 0.07% | +641.0 | +2.5% | $9.72 | +3.2% |
| 312 | JBIO | JADE BIOSCIENCES INC | Healthcare | 18,203.0 | $256K | 0.07% | +444.0 | +2.5% | $14.05 | +53.0% |
| 313 | SION | SIONNA THERAPEUTICS INC | Healthcare | 6,374.0 | $256K | 0.07% | +154.0 | +2.5% | $40.09 | +8.3% |
| 314 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 3,040.0 | $253K | 0.07% | +74.0 | +2.5% | $83.29 | -1.9% |
| 315 | COGT | COGENT BIOSCIENCES INC | Healthcare | 6,476.0 | $249K | 0.07% | +159.0 | +2.5% | $38.49 | -10.3% |
| 316 | JANX | JANUX THERAPEUTICS INC | Healthcare | 17,821.0 | $248K | 0.07% | +433.0 | +2.5% | $13.90 | +3.9% |
| 317 | — | BCP INVESTMENT CORPORATION | — | 32,830.0 | $247K | 0.07% | -475.0 | -1.4% | $7.52 | — |
| 318 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 7,354.0 | $239K | 0.07% | +180.0 | +2.5% | $32.54 | -2.7% |
| 319 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 9,966.0 | $237K | 0.07% | +242.0 | +2.5% | $23.83 | +33.8% |
| 320 | — | NEWAMSTERDAM PHARMA COMPANY | — | 7,319.0 | $234K | 0.07% | +177.0 | +2.5% | $32.01 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
30.6%
Financial Services
23.4%
Industrials
11.2%
Technology
10.7%
Consumer Cyclical
7.6%
Energy
3.4%
Basic Materials
3.4%
Communication Services
3.1%
Consumer Defensive
2.9%
Real Estate
2.2%